PDT Partners’s Viemed Healthcare VMD Stock Holding History

PDT Partners’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$216K	Sell	23,472 -4,293	-15%	-$35.7K	0.01%	490
2025 Q4	$206K	Sell	27,765 -16,005	-37%	-$110K	0.01%	512
2025 Q3	$297K	Hold	43,770	–	–	0.02%	509
2025 Q2	$302K	Buy	43,770 +12,337	+39%	+$83.7K	0.02%	597
2025 Q1	$229K	Buy	31,433 +106	+0.3%	+$832	0.02%	656
2024 Q4	$251K	Buy	31,327 +20,728	+196%	+$180K	0.02%	615
2024 Q3	$77.7K	Buy	+10,599	New	+$75.7K	0.01%	700
2023 Q4	–	Sell	-11,830	Closed	-$79.6K	–	680
2023 Q3	$79.6K	Sell	11,830 -2,423	-17%	-$19.9K	0.01%	559
2023 Q2	$139K	Buy	+14,253	New	+$145K	0.02%	521
2022 Q2	–	Sell	-21,294	Closed	-$106K	–	1170
2022 Q1	$106K	Buy	21,294 +3,917	+23%	+$18.2K	0.01%	864
2021 Q4	$91K	Sell	17,377 -15,206	-47%	-$84.9K	0.01%	828
2021 Q3	$181K	Buy	32,583 +4,583	+16%	+$29.8K	0.01%	704
2021 Q2	$200K	Buy	+28,000	New	+$243K	0.01%	704

Other funds holding VMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

PDT Partners's VMD Position: Q1 2026 in Review

PDT Partners reduced its Viemed Healthcare (VMD) stake by 15% in Q1 2026, selling an estimated $35.7K and leaving 23,472 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #490.

PDT Partners first reported a position in VMD in Q2 2021 and has held it in 13 quarters since. The position peaked at $302K in Q2 2025. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

PDT Partners held 23,472 shares of Viemed Healthcare worth $216K as of Q1 2026.
PDT Partners sold 4,293 Viemed Healthcare shares in Q1 2026, an estimated $35.7K.
Viemed Healthcare made up 0.01% of PDT Partners's portfolio in Q1 2026, its #490 holding.
PDT Partners first reported a position in Viemed Healthcare in Q2 2021 and has held it in 13 quarters since.
PDT Partners's Viemed Healthcare position peaked at $302K in Q2 2025.
149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.